Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

Contrast induced nephropathy in patients undergoing intravenous (IV) contrast enhanced computed tomography (CECT) and the relationship with risk factors: a meta-analysis.

Moos SI, van Vemde DN, Stoker J, Bipat S.

Eur J Radiol. 2013 Sep;82(9):e387-99. doi: 10.1016/j.ejrad.2013.04.029. Epub 2013 May 25.

PMID:
23711425
2.

Prediction of presence of kidney disease in a general patient population undergoing intravenous iodinated contrast enhanced computed tomography.

Moos SI, Stoker J, Nagan G, de Weijert RS, van Vemde DN, Bipat S.

Eur Radiol. 2014 Jun;24(6):1266-75. doi: 10.1007/s00330-014-3149-2. Epub 2014 Mar 25.

PMID:
24663822
3.

Contrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material: risk stratification by using estimated glomerular filtration rate.

Davenport MS, Khalatbari S, Cohan RH, Dillman JR, Myles JD, Ellis JH.

Radiology. 2013 Sep;268(3):719-28. doi: 10.1148/radiol.13122276. Epub 2013 Apr 11.

PMID:
23579046
4.

Contrast-induced nephropathy in patients undergoing intravenous contrast-enhanced computed tomography in Korea: a multi-institutional study in 101487 patients.

Lee J, Cho JY, Lee HJ, Jeong YY, Kim CK, Park BK, Sung DJ, Kang BC, Jung SI, Lee EJ, Yi BH, Park SJ, Kim JC, Jung DC, Sung CK, Kim Y, Lee Y, Kim SH, Yoon SK, Park BJ, Kim SH; Korean Society of Urogenital Radiology (KSUR); Korean Society of Radiology.

Korean J Radiol. 2014 Jul-Aug;15(4):456-63. doi: 10.3348/kjr.2014.15.4.456. Epub 2014 Jul 9.

5.

Incidence of nonconfounded post-computed tomography acute kidney injury in hospitalized patients with stable renal function receiving intravenous iodinated contrast material.

Moore A, Dickerson E, Dillman JR, Vummidi D, Kershaw DB, Khalatbari S, Davenport MS.

Curr Probl Diagn Radiol. 2014 Sep-Oct;43(5):237-41. doi: 10.1067/j.cpradiol.2014.05.001. Epub 2014 Jun 6.

PMID:
24909428
6.

Prevalence of risk factors for contrast-induced nephrotoxicity in outpatients undergoing intravenous contrast-enhanced computed tomography studies.

Carstensen M, Keer D, Rempel J, Jeon P, Barrett B.

Can Assoc Radiol J. 2012 Aug;63(3):177-82. doi: 10.1016/j.carj.2010.12.004. Epub 2011 Oct 26.

7.

Risk factors for acute kidney injury in the elderly undergoing contrast-enhanced computed tomography in the emergency department.

Huang MK, Hsu TF, Chiu YH, Chiang SC, Kao WF, Yen DH, Huang MS.

J Chin Med Assoc. 2013 May;76(5):271-6. doi: 10.1016/j.jcma.2013.01.007. Epub 2013 Mar 21.

8.

Meta-analysis: serum creatinine changes following contrast enhanced CT imaging.

Kooiman J, Pasha SM, Zondag W, Sijpkens YW, van der Molen AJ, Huisman MV, Dekkers OM.

Eur J Radiol. 2012 Oct;81(10):2554-61. doi: 10.1016/j.ejrad.2011.11.020. Epub 2011 Dec 15.

PMID:
22177326
9.

Anemia and the risk of contrast-induced nephropathy in patients with renal insufficiency undergoing contrast-enhanced MDCT.

Murakami R, Kumita S, Hayashi H, Sugizaki K, Okazaki E, Kiriyama T, Hakozaki K, Tani H, Miki I, Takeda M.

Eur J Radiol. 2013 Oct;82(10):e521-4. doi: 10.1016/j.ejrad.2013.06.004. Epub 2013 Jul 1.

PMID:
23827802
10.

Follow up for emergency department patients after intravenous contrast and risk of nephropathy.

Hassen GW, Hwang A, Liu LL, Mualim F, Sembo T, Tu TJ, Wei DH, Johnston P, Costea A, Meletiche C, Usmani S, Barber A, Jaiswal R, Kalantari H.

West J Emerg Med. 2014 May;15(3):276-81. doi: 10.5811/westjem.2013.8.17915. Epub 2014 Jan 7.

11.

Theophylline for prevention of contrast-induced nephropathy: a systematic review and meta-analysis.

Bagshaw SM, Ghali WA.

Arch Intern Med. 2005 May 23;165(10):1087-93. Review.

PMID:
15911721
12.

Effectiveness of theophylline in preventing contrast-induced nephropathy after coronary angiographic procedures.

Bilasy ME, Oraby MA, Ismail HM, Maklady FA.

J Interv Cardiol. 2012 Aug;25(4):404-10. doi: 10.1111/j.1540-8183.2012.00730.x. Epub 2012 May 22.

PMID:
22612071
13.

Risk of contrast-induced nephropathy in patients undergoing endovascular treatment of acute ischemic stroke.

Sharma J, Nanda A, Jung RS, Mehta S, Pooria J, Hsu DP.

J Neurointerv Surg. 2013 Nov;5(6):543-5. doi: 10.1136/neurintsurg-2012-010520. Epub 2012 Nov 2.

PMID:
23125428
14.

Contrast-medium-Induced nephropathy correlated to the ratio between dose in gram iodine and estimated GFR in ml/min.

Nyman U, Almén T, Aspelin P, Hellström M, Kristiansson M, Sterner G.

Acta Radiol. 2005 Dec;46(8):830-42.

PMID:
16392608
15.

Efficacy of patient questionnaire in predicting renal dysfunction in outpatients older than 60 years of age prior to contrast-enhanced computed tomography.

Lui EH, Lau KK, Polkinghorne K, Chang CA, Ardley N.

J Med Imaging Radiat Oncol. 2012 Apr;56(2):168-72. doi: 10.1111/j.1754-9485.2011.02323.x.

PMID:
22498189
16.

Prediction of contrast-induced nephropathy in diabetics undergoing elective percutaneous coronary intervention: role of the ratio of contrast medium volume to estimated glomerular filtration rate.

Wang XC, Fu XH, Wang YB, Jia XW, Wu WL, Gu XS, Zhang J, Su JL, Hao GZ, Jiang YF, Fan WZ, Li SQ.

Chin Med J (Engl). 2011 Mar;124(6):892-6.

PMID:
21518598
17.

Risk of contrast-medium-induced nephropathy in high-risk patients undergoing MDCT--a pooled analysis of two randomized trials.

Thomsen HS, Morcos SK.

Eur Radiol. 2009 Apr;19(4):891-7. doi: 10.1007/s00330-008-1206-4. Epub 2008 Nov 11.

PMID:
19002467
18.

Prediction of presence of kidney disease in patients undergoing intravenous iodinated contrast enhanced computed tomography: a validation study.

Schreuder SM, Stoker J, Bipat S.

Eur Radiol. 2017 Apr;27(4):1613-1621. doi: 10.1007/s00330-016-4478-0. Epub 2016 Jul 19.

19.

Incidence of contrast-induced nephropathy after contrast-enhanced computed tomography in the outpatient setting.

Mitchell AM, Jones AE, Tumlin JA, Kline JA.

Clin J Am Soc Nephrol. 2010 Jan;5(1):4-9. doi: 10.2215/CJN.05200709. Epub 2009 Dec 3.

20.

The incidence of contrast-induced nephropathy in trauma patients.

Hipp A, Desai S, Lopez C, Sinert R.

Eur J Emerg Med. 2008 Jun;15(3):134-9. doi: 10.1097/MEJ.0b013e328270367d.

PMID:
18460952

Supplemental Content

Support Center